GLUCONATURE
Natural health product licensed in Canada
- Licence holder
- Lumina Plant
- NPN or DIN-HM
- 80061281
- Status
- Active licence
- Licence date
- 28 May 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Senna obtusifolia (L.) H.S.Irwin & Barneby: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax quinquefolius Source : Racine | 85 mg | Not calculated |
| Salvia miltiorrhiza Source : Extrait de racine Extraction ratio : 5:1 Dry plant equivalent : 900 mg | 180 mg | Not calculated |
| Polygonatum odoratum Source : Rhizome Extract Extraction ratio : 5:1 Dry plant equivalent : 50 mg | 10 mg | Not calculated |
| Astragalus membranaceus Source : Racine | 30 mg | Not calculated |
| Gynostemma pentaphyllum Source : Aerial parts extract Extraction ratio : 5:1 Dry plant equivalent : 80 mg | 16 mg | Not calculated |
| Polygonatum cirrhifolium Source : Racine | 50 mg | Not calculated |
| Ganoderma lucidum Source : Corps fructifère | 10 mg | Not calculated |
| Momordica charantia Source : Fruit | 20 mg | Not calculated |
| Senna obtusifolia Source : Seed extract Extraction ratio : 5:1 Dry plant equivalent : 750 mg | 150 mg | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. American Ginseng is traditionally used in Herbal Medicine to help relieve nervousness (as mild sedative). American Ginseng is traditionally used in Herbal Medicine to help relieve nervous dyspepsia / to help digestion in cases of nervousness and/or stress. American Ginseng is traditionally used in Herbal Medicine to help maintain a healthy immune system. American Ginseng is traditionally used in Herbal Medicine to help relieve nervouseness (sedative and/or calmative). American Ginseng is traditionally used in Herbal Medicine as a sleep aid (in cases of restlessness or insomnia due to mental stress). Source of/Provides antioxidants. Source of fungal polysaccharides with immunomodulating properties.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061281
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.